Multicenter comparison of high-dose cytarabine-based regimens versus liposomal daunorubicin and cytarabine (CPX-351) in patients with secondary acute myeloid leukemia.

Saved in:
Bibliographic Details
Title: Multicenter comparison of high-dose cytarabine-based regimens versus liposomal daunorubicin and cytarabine (CPX-351) in patients with secondary acute myeloid leukemia.
Authors: Benitez LL; Michigan Medicine, Ann Arbor, MI, USA.; College of Pharmacy, University of Michigan, Ann Arbor, MI, USA., Perissinotti AJ; Michigan Medicine, Ann Arbor, MI, USA., Rausch CR; The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Klaus J; Barnes Jewish Hospital, St. Louis, MO, USA., Clark SM; University of North Carolina Medical Center, Chapel Hill, NC, USA., Filtz M; Huntsman Cancer Institute, Salt Lake City, UT, USA., Ratermann K; Huntsman Cancer Institute, Salt Lake City, UT, USA., Treptow C; Department of Pharmacy, University of Rochester, Rochester, NY, USA., Griffin S; Indiana University Health, Indianapolis, IN, USA., Olson M; Barnes Jewish Hospital, St. Louis, MO, USA., Crain M; Barnes Jewish Hospital, St. Louis, MO, USA., Kadia T; The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Pettit K; Michigan Medicine, Ann Arbor, MI, USA., Burke PW; Michigan Medicine, Ann Arbor, MI, USA., Bixby DL; Michigan Medicine, Ann Arbor, MI, USA., Marini BL; Michigan Medicine, Ann Arbor, MI, USA.; College of Pharmacy, University of Michigan, Ann Arbor, MI, USA.
Source: Leukemia & lymphoma [Leuk Lymphoma] 2021 Sep; Vol. 62 (9), pp. 2184-2192. Date of Electronic Publication: 2021 Apr 08.
Publication Type: Journal Article; Multicenter Study; Research Support, N.I.H., Extramural
Journal Info: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1029-2403
DOI:10.1080/10428194.2021.1907378